Dr. Ronald Villanueva, MD (he/him) is an Endocrinologist in Toms river, NJ with over 16 years of experience. What is your opinion of Dr. Ronald Villanueva, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ronald Villanueva, MD has received over $324,635 which includes payments from the following companies:
$215,797.08 from AstraZeneca Pharmaceuticals LP
$32,078.85 from sanofi-aventis U.S. LLC
$27,781.93 from Boehringer Ingelheim Pharmaceuticals, Inc.
$21,093.90 from AbbVie, Inc.
$9,612.07 from LILLY USA, LLC
$5,255.41 from Novo Nordisk Inc
$3,538.41 from GlaxoSmithKline, LLC.
$970.48 from Janssen Pharmaceuticals, Inc
$969.10 from Valeritas, Inc.
$811.45 from Medtronic MiniMed, Inc.
$713.47 from Merck Sharp & Dohme Corporation
$576.28 from Takeda Pharmaceuticals America, Inc.
$376.17 from INSULET CORPORATION
$368.11 from Abbott Laboratories
$342.39 from Amgen Inc.
$329.29 from Gemini Laboratories, LLC
$292.07 from Amarin Pharma Inc.
$285.00 from Animas Corporation
$270.69 from GENZYME CORPORATION
$228.91 from MannKind Corporation
Payments received by Dr. Ronald Villanueva, MD were from the following categories:
$284,073.91 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!